How can we improve rural mental health?
John Kraus, MD, PhD
Advertisement
Articles by John Kraus, MD, PhD
Rejoyn was recently cleared by the FDA, making it the first prescription digital therapeutic for major depressive disorder.
New research explores ulotaront as an adjunctive therapy for adults with major depressive disorder.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Interdisciplinary Consensus Guidelines on Stuttering (Childhood-Onset Fluency Disorder): Addressing Issues in Diagnosis, Treatment, and Unmet Needs
2
DT120 (Lysergide) Shows Rapid, Lasting Relief for Generalized Anxiety in Phase 3 Trial
3
TRD: Matching Patients to the Right Treatment
4
Phase 4 Trial of Viloxazine ER Shows Real-World Gains for ADHD With Comorbid Depression, Anxiety
5